Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heideman

Showing results (101-110 of 272) with videos related to

Pageof 28
Sort By:
International Journal of Cancer|August 4, 2023
Methylation testing for the detection of recurrent cervical intraepithelial neoplasiaStèfanie Dick, Daniëlle A M Heideman, Constantijne H Mom, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2013
KRAS mutations in advanced nonsquamous non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy have no predictive valueWouter W Mellema, Anne-Marie C Dingemans, Erik Thunnissen, et al.
Oncotarget|April 19, 2017
Development of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenograftsPaul Slobbe, Albert D Windhorst, Kevin Adamzek, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2015
Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?Julien P L Vincenten, Egbert F Smit, Katrien Grünberg, et al.
International Journal of Cancer|February 15, 2018
Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesionsM M Rietbergen, A A J D van Bokhoven, B I Lissenberg-Witte, et al.
Sexually Transmitted Infections|March 26, 2016
Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literatureWouter B van der Sluis, Marlon E Buncamper, Mark-Bram Bouman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 26, 2016
Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screeningA T Hesselink, R Sahli, J Berkhof, et al.
Emerging Infectious Diseases|December 22, 2020
Impact of Human Papillomavirus Vaccination, Rwanda and BhutanIacopo Baussano, Felix Sayinzoga, Ugyen Tshomo, et al.
Cancer Medicine|March 31, 2023
Human papillomavirus testing on self-collected samples to detect high-grade cervical lesions in rural Bhutan: The REACH-Bhutan studyGary M Clifford, Iacopo Baussano, Daniëlle A M Heideman, et al.
BMC Infectious Diseases|September 19, 2024
Population-based age- and type-specific prevalence of human papillomavirus among non-vaccinated women aged 30 years and above in GermanyLinda A Liang, Luana F Tanaka, Kathrin Radde, et al.
Pageof 28

Showing results (101-110 of 272) with videos related to

Sort By:
Pageof 28
International Journal of Cancer|August 4, 2023
Methylation testing for the detection of recurrent cervical intraepithelial neoplasiaStèfanie Dick, Daniëlle A M Heideman, Constantijne H Mom, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 22, 2013
KRAS mutations in advanced nonsquamous non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy have no predictive valueWouter W Mellema, Anne-Marie C Dingemans, Erik Thunnissen, et al.
Oncotarget|April 19, 2017
Development of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenograftsPaul Slobbe, Albert D Windhorst, Kevin Adamzek, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2015
Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?Julien P L Vincenten, Egbert F Smit, Katrien Grünberg, et al.
International Journal of Cancer|February 15, 2018
Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesionsM M Rietbergen, A A J D van Bokhoven, B I Lissenberg-Witte, et al.
Sexually Transmitted Infections|March 26, 2016
Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literatureWouter B van der Sluis, Marlon E Buncamper, Mark-Bram Bouman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 26, 2016
Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screeningA T Hesselink, R Sahli, J Berkhof, et al.
Emerging Infectious Diseases|December 22, 2020
Impact of Human Papillomavirus Vaccination, Rwanda and BhutanIacopo Baussano, Felix Sayinzoga, Ugyen Tshomo, et al.
Cancer Medicine|March 31, 2023
Human papillomavirus testing on self-collected samples to detect high-grade cervical lesions in rural Bhutan: The REACH-Bhutan studyGary M Clifford, Iacopo Baussano, Daniëlle A M Heideman, et al.
BMC Infectious Diseases|September 19, 2024
Population-based age- and type-specific prevalence of human papillomavirus among non-vaccinated women aged 30 years and above in GermanyLinda A Liang, Luana F Tanaka, Kathrin Radde, et al.
Pageof 28